Loading... Please wait...
App Store Download on the App Store Google Play GET IT ON Google Play

Acrivon Therapeutics, Inc. Common Stock (ACRV) Analyst Forecast

Currency in USD Disclaimer
Add to Alerts
Add to Watchlist
$6.14 $0.06 (0.99%)
$5.81
$6.15
$3.19
$13.5

  • Consensus Price Target

    $22.00

    258.31% Upside

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside on Report Date Details
05/14/2024 Oppenheimer Matthew Biegler $21.00 $8.36   151.2%
05/14/2024 H.C. Wainwright Emily Bodnar $22.00 $8.35   163.63%
05/14/2024 BMO Capital Etzer Darout $25.00 $8.51   193.77%
04/25/2024 Piper Sandler Joseph Catanzaro $30.00 $9.20   226.09%
04/25/2024 JMP Securities Silvan Tuerkcan $17.00 $9.50   78.95%
03/28/2024 H.C. Wainwright Emily Bodnar $20.00 $7.19   178.36%
12/11/2022 Piper Sandler Joseph Catanzaro $25.00 $12.50   100%

Acrivon Therapeutics, Inc. Common Stock Frequently Asked Questions

  • Q. What analysts cover Acrivon Therapeutics, Inc. Common Stock?

    A. Acrivon Therapeutics, Inc. Common Stock has been rated by research analysts at Oppenheimer, H.C. Wainwright, BMO Capital, Piper Sandler, JMP Securities, Jefferies in the past 90 days.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In

or
Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Sign Up With Email Address
or
Continue with Google Continue with Apple

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.